[Case report; a case of acute kidney injury due to intravenous zoledronic acid hydrate, improved with bortezomib plus dexamethazone therapy in a patient with multiple myeloma]

Nihon Naika Gakkai Zasshi. 2011 Jan 10;100(1):179-81. doi: 10.2169/naika.100.179.
[Article in Japanese]
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Acute Kidney Injury / chemically induced*
  • Adult
  • Antineoplastic Agents / administration & dosage*
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents, Hormonal / administration & dosage*
  • Boronic Acids / administration & dosage*
  • Bortezomib
  • Dexamethasone / administration & dosage*
  • Diphosphonates / administration & dosage
  • Diphosphonates / adverse effects*
  • Drug Therapy, Combination
  • Humans
  • Imidazoles / administration & dosage
  • Imidazoles / adverse effects*
  • Injections, Intravenous
  • Male
  • Multiple Myeloma / drug therapy*
  • Pyrazines / administration & dosage*
  • Zoledronic Acid

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Hormonal
  • Boronic Acids
  • Diphosphonates
  • Imidazoles
  • Pyrazines
  • Bortezomib
  • Zoledronic Acid
  • Dexamethasone